BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30521999)

  • 1. Examining the factor structure of the self-report Yale-Brown Obsessive Compulsive Scale Symptom Checklist.
    du Mortier JAM; Visser HAD; van Balkom AJLM; van Megen HJGM; Hoogendoorn AW; Glas G; van Oppen P
    Psychiatry Res; 2019 Jan; 271():299-305. PubMed ID: 30521999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist.
    Storch EA; Larson MJ; Price LH; Rasmussen SA; Murphy TK; Goodman WK
    J Anxiety Disord; 2010 Aug; 24(6):650-6. PubMed ID: 20471199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist.
    Sulkowski ML; Storch EA; Geffken GR; Ricketts E; Murphy TK; Goodman WK
    J Clin Psychol; 2008 Dec; 64(12):1338-51. PubMed ID: 18942133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor analysis of Y-BOCS checklist and severity scale among patients with schizophrenia.
    Grover S; Dua D; Chakrabarti S; Avasthi A
    Asian J Psychiatr; 2017 Apr; 26():141-145. PubMed ID: 28483079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationships between obsessive-compulsive symptom dimensions and cognitions in obsessive-compulsive disorder.
    Brakoulias V; Starcevic V; Berle D; Milicevic D; Hannan A; Martin A
    Psychiatr Q; 2014 Jun; 85(2):133-42. PubMed ID: 24142072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disorders.
    Bejerot S; Edman G; Anckarsäter H; Berglund G; Gillberg C; Hofvander B; Humble MB; Mörtberg E; Råstam M; Ståhlberg O; Frisén L
    Nord J Psychiatry; 2014 Nov; 68(8):549-59. PubMed ID: 24568661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hoarding symptoms and prediction of poor response to limbic system surgery for treatment-refractory obsessive-compulsive disorder.
    Gentil AF; Lopes AC; Dougherty DD; Rück C; Mataix-Cols D; Lukacs TL; Canteras MM; Eskandar EN; Larsson KJ; Hoexter MQ; Batistuzzo MC; Greenberg BD; Miguel EC
    J Neurosurg; 2014 Jul; 121(1):123-30. PubMed ID: 24702323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between miscellaneous symptoms and primary symptom dimensions among chinese adults with obsessive-compulsive disorder.
    Zhou Y; Cao X; Wang J; Gao R; Chen Y; Liu Y; Zhang Z; Wang Z; Storch EA; Fan Q
    Psychiatry Res; 2019 Apr; 274():274-279. PubMed ID: 30825727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive-compulsive symptom dimensions in schizophrenia patients with comorbid obsessive-compulsive disorder.
    Faragian S; Pashinian A; Fuchs C; Poyurovsky M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1009-12. PubMed ID: 19447155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring yale-brown obsessive-compulsive scale symptom structure in Iranian OCD patients using item-based factor analysis.
    Asadi S; Daraeian A; Rahmani B; Kargari A; Ahmadiani A; Shams J
    Psychiatry Res; 2016 Nov; 245():416-422. PubMed ID: 27620324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and preliminary psychometric evaluation of the Children's Saving Inventory.
    Storch EA; Muroff J; Lewin AB; Geller D; Ross A; McCarthy K; Morgan J; Murphy TK; Frost R; Steketee G
    Child Psychiatry Hum Dev; 2011 Apr; 42(2):166-82. PubMed ID: 20886284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measure.
    Denys D; de Geus F; van Megen HJ; Westenberg HG
    Psychopathology; 2004; 37(4):181-9. PubMed ID: 15240990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validation of the Hungarian version of the dimensional Yale-Brown obsessive-compulsive scale.
    Harsányi A; Csigó K; Rajkai C; Döme L; Demeter G; Racsmány M
    Ideggyogy Sz; 2012 Jan; 65(1-2):25-33. PubMed ID: 22338843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and clinical correlates of obsessive-compulsive symptoms in a large sample of children and adolescents: a factor analytic study across five nations.
    Højgaard DR; Mortensen EL; Ivarsson T; Hybel K; Skarphedinsson G; Nissen JB; Valderhaug R; Dahl K; Weidle B; Torp NC; Grados M; Lewin AB; Melin KH; Storch EA; Wolters LH; Murphy TK; Sonuga-Barke EJ; Thomsen PH
    Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):281-291. PubMed ID: 27388606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergent and discriminant validity of the Yale-Brown Obsessive-Compulsive Scale Symptom Checklist.
    Mataix-Cols D; Fullana MA; Alonso P; Menchón JM; Vallejo J
    Psychother Psychosom; 2004; 73(3):190-6. PubMed ID: 15031592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Yale-Brown Obsessive Compulsive Scale: factor analysis, construct validity, and suggestions for refinement.
    Deacon BJ; Abramowitz JS
    J Anxiety Disord; 2005; 19(5):573-85. PubMed ID: 15749574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principal components analysis of obsessive-compulsive disorder symptoms in children and adolescents.
    Stewart SE; Rosario MC; Brown TA; Carter AS; Leckman JF; Sukhodolsky D; Katsovitch L; King R; Geller D; Pauls DL
    Biol Psychiatry; 2007 Feb; 61(3):285-91. PubMed ID: 17161383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsessive Compulsive Symptoms/disorder in patients with schizophrenia: Prevalence, relationship with other symptom dimensions and impact on functioning.
    Grover S; Dua D; Chakrabarti S; Avasthi A
    Psychiatry Res; 2017 Apr; 250():277-284. PubMed ID: 28189922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder.
    Williams MT; Farris SG; Turkheimer EN; Franklin ME; Simpson HB; Liebowitz M; Foa EB
    J Anxiety Disord; 2014 Aug; 28(6):553-8. PubMed ID: 24983796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.